{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T13:57:53Z","timestamp":1782568673590,"version":"3.54.5"},"reference-count":43,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,29]],"date-time":"2021-09-29T00:00:00Z","timestamp":1632873600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Immunology"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.humimm.2021.09.006","type":"journal-article","created":{"date-parts":[[2021,10,8]],"date-time":"2021-10-08T20:50:47Z","timestamp":1633726247000},"page":"53-60","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Associations of human leukocyte antigen with neutralizing antibody titers in a tetravalent dengue vaccine phase 2 efficacy trial in Thailand"],"prefix":"10.1016","volume":"83","author":[{"given":"Rasmi","family":"Thomas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danaya","family":"Chansinghakul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2990-6530","authenticated-orcid":false,"given":"Kriengsak","family":"Limkittikul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter B.","family":"Gilbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0250-6737","authenticated-orcid":false,"given":"Weerawan","family":"Hattasingh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8701-2001","authenticated-orcid":false,"given":"Zoe","family":"Moodie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shida","family":"Shangguan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carina","family":"Frago","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wut","family":"Dulyachai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuying Sue","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard G.","family":"Jarman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aviva","family":"Geretz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Bouckenooghe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arunee","family":"Sabchareon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0920-2915","authenticated-orcid":false,"given":"Michal","family":"Juraska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Ehrenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5882-5548","authenticated-orcid":false,"given":"Nelson L.","family":"Michael","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrice","family":"Bailleux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2118-6062","authenticated-orcid":false,"given":"Chris","family":"Bryant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay","family":"Gurunathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.humimm.2021.09.006_b0005","first-page":"457","article-title":"Dengue vaccine: Who position paper \u2013 september 2018","volume":"93","author":"World Health Organization","year":"2018","journal-title":"Wkly Epidemiol. Rec."},{"key":"10.1016\/j.humimm.2021.09.006_b0010","doi-asserted-by":"crossref","first-page":"293","DOI":"10.4103\/0972-9062.197259","article-title":"The epidemiology of dengue infection: Harnessing past experience and current knowledge to support implementation of future control strategies","volume":"53","author":"Gyawali","year":"2016","journal-title":"J. Vector Borne Dis."},{"key":"10.1016\/j.humimm.2021.09.006_b0015","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1016\/S0140-6736(12)61428-7","article-title":"Protective efficacy of the recombinant, live-attenuated, cyd tetravalent dengue vaccine in thai schoolchildren: a randomised, controlled phase 2b trial","volume":"380","author":"Sabchareon","year":"2012","journal-title":"Lancet"},{"issue":"13","key":"10.1016\/j.humimm.2021.09.006_b0020","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1056\/NEJMoa1506223","article-title":"Efficacy and long-term safety of a dengue vaccine in regions of endemic disease","volume":"373","author":"Hadinegoro","year":"2015","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.humimm.2021.09.006_b0025","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1056\/NEJMoa1800820","article-title":"Effect of dengue serostatus on dengue vaccine safety and efficacy","volume":"379","author":"Sridhar","year":"2018","journal-title":"N. Engl. J. Med."},{"issue":"14","key":"10.1016\/j.humimm.2021.09.006_b0030","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1056\/NEJMoa1113425","article-title":"Immune-correlates analysis of an hiv-1 vaccine efficacy trial","volume":"366","author":"Haynes","year":"2012","journal-title":"N. Engl. J. Med."},{"issue":"7","key":"10.1016\/j.humimm.2021.09.006_b0035","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1128\/CVI.00131-10","article-title":"Correlates of protection induced by vaccination","volume":"17","author":"Plotkin","year":"2010","journal-title":"Clin. Vaccine Immunol."},{"key":"10.1016\/j.humimm.2021.09.006_b0040","doi-asserted-by":"crossref","first-page":"4758","DOI":"10.1002\/sim.3122","article-title":"Evaluating a surrogate endpoint at three levels, with application to vaccine development","volume":"27","author":"Gilbert","year":"2008","journal-title":"Stat. Med."},{"issue":"2","key":"10.1016\/j.humimm.2021.09.006_b0045","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.micinf.2008.12.006","article-title":"Human genetic determinants of dengue virus susceptibility","volume":"11","author":"Coffey","year":"2009","journal-title":"Microbes Infect."},{"key":"10.1016\/j.humimm.2021.09.006_b0050","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1034\/j.1399-0039.2002.600405.x","article-title":"Hla-a and -b allele associations with secondary dengue virus infections correlate with disease severity and the infecting viral serotype in ethnic thais","volume":"60","author":"Stephens","year":"2002","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.humimm.2021.09.006_b0055","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1093\/infdis\/jix609","article-title":"Neutralizing antibody correlates analysis of tetravalent dengue vaccine efficacy trials in asia and latin america","volume":"217","author":"Moodie","year":"2018","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.humimm.2021.09.006_b0060","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/j.1574-695X.2006.00058.x","article-title":"Dengue and dengue haemorrhagic fever: Implications of host genetics","volume":"47","author":"Chaturvedi","year":"2006","journal-title":"FEMS Immunol. Med. Microbiol."},{"issue":"5","key":"10.1016\/j.humimm.2021.09.006_b0065","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1086\/500144","article-title":"Human leukocyte antigen haplotypes in the genetic control of immune response to measles-mumps-rubella vaccine","volume":"193","author":"Ovsyannikova","year":"2006","journal-title":"J. Infect. Dis."},{"issue":"6","key":"10.1016\/j.humimm.2021.09.006_b0070","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1046\/j.1523-1755.1998.00909.x","article-title":"Distinct hla class ii alleles determine antibody response to vaccination with hepatitis b surface antigen","volume":"53","author":"Caillat-Zucman","year":"1998","journal-title":"Kidney Int."},{"issue":"11","key":"10.1016\/j.humimm.2021.09.006_b0075","doi-asserted-by":"crossref","first-page":"3142","DOI":"10.1002\/eji.1830251123","article-title":"The presence of the hla class ii allele dpb1*0501 in ethnic thais correlates with an enhanced vaccine-induced antibody response to a malaria sporozoite antigen","volume":"25","author":"Stephens","year":"1995","journal-title":"Eur. J. Immunol."},{"issue":"1","key":"10.1016\/j.humimm.2021.09.006_b0080","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1159\/000463067","article-title":"Complotypes and extended haplotypes in laboratory medicine","volume":"6","author":"Alper","year":"1989","journal-title":"Complement Inflamm."},{"key":"10.1016\/j.humimm.2021.09.006_b0085","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.vaccine.2011.11.002","article-title":"Hla class ii restriction of hiv-1 clade-specific neutralizing antibody responses in ethnic thai recipients of the rv144 prime-boost vaccine combination of alvac-hiv and aidsvax((r)) b\/e","volume":"30","author":"Paris","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.humimm.2021.09.006_b0090","doi-asserted-by":"crossref","first-page":"296ra112","DOI":"10.1126\/scitranslmed.aab4005","article-title":"Hla class ii genes modulate vaccine-induced antibody responses to affect hiv-1 acquisition","volume":"7","author":"Prentice","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.humimm.2021.09.006_b0095","first-page":"396","article-title":"Long-term safety follow-up of children from a randomized-controlled phase ii b proof-of-concept efficacy study of the live, attenuated, tetravalent dengue vaccine (cyd-tdv) in thailand, Asian Pac","volume":"12","author":"Limkittikul","year":"2019","journal-title":"J Trop Med."},{"key":"10.1016\/j.humimm.2021.09.006_b0100","doi-asserted-by":"crossref","first-page":"962","DOI":"10.4269\/ajtmh.12-0461","article-title":"Optimization and validation of a plaque reduction neutralization test for the detection of neutralizing antibodies to four serotypes of dengue virus used in support of dengue vaccine development","volume":"88","author":"Timiryasova","year":"2013","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.humimm.2021.09.006_b0105","first-page":"65","article-title":"A simple sequentially rejective multiple test procedure","volume":"6","author":"Holm","year":"1979","journal-title":"Scand. J. Stat."},{"issue":"1-2","key":"10.1016\/j.humimm.2021.09.006_b0110","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0166-4328(01)00297-2","article-title":"Controlling the false discovery rate in behavior genetics research","volume":"125","author":"Benjamini","year":"2001","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.humimm.2021.09.006_b0115","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/sim.4780080407","article-title":"Surrogate endpoints in clinical trials: Definition and operational criteria","volume":"8","author":"Prentice","year":"1989","journal-title":"Stat. Med."},{"key":"10.1016\/j.humimm.2021.09.006_b0120","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1093\/biostatistics\/kxy074","article-title":"Inference on treatment effect modification by biomarker response in a three-phase sampling design","volume":"21","author":"Juraska","year":"2018","journal-title":"Biostatistics"},{"issue":"11","key":"10.1016\/j.humimm.2021.09.006_b0125","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.humimm.2018.09.005","article-title":"Full-length next-generation sequencing of hla class i and ii genes in a cohort from thailand","volume":"79","author":"Geretz","year":"2018","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.humimm.2021.09.006_b0130","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/tan.13133","article-title":"High-throughput next-generation sequencing to genotype six classical hla loci from 96 donors in a single miseq run","volume":"90","author":"Ehrenberg","year":"2017","journal-title":"HLA"},{"issue":"5","key":"10.1016\/j.humimm.2021.09.006_b0135","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s00251-014-0765-6","article-title":"Hla class i, kir, and genome-wide snp diversity in the rv144 thai phase 3 hiv vaccine clinical trial","volume":"66","author":"Prentice","year":"2014","journal-title":"Immunogenetics"},{"issue":"2","key":"10.1016\/j.humimm.2021.09.006_b0140","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/tan.12507","article-title":"Hla class ii diversity in hiv-1 uninfected individuals from the placebo arm of the rv144 thai vaccine efficacy trial","volume":"85","author":"Baldwin","year":"2015","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.humimm.2021.09.006_b0145","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1086\/519795","article-title":"Plink: A tool set for whole-genome association and population-based linkage analyses","volume":"81","author":"Purcell","year":"2007","journal-title":"Am. J. Hum. Genet."},{"issue":"1","key":"10.1016\/j.humimm.2021.09.006_b0150","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1093\/biostatistics\/kxt018","article-title":"Case-only method for cause-specific hazards models with application to assessing differential vaccine efficacy by viral and host genetics","volume":"15","author":"Dai","year":"2014","journal-title":"Biostatistics"},{"key":"10.1016\/j.humimm.2021.09.006_b0155","doi-asserted-by":"crossref","unstructured":"M.A. Rabaa, Y. Girerd-Chambaz, K. Duong Thi Hue, T. Vu Tuan, B. Wills, M. Bonaparte, D. van der Vliet, E. Langevin, M. Cortes, B. Zambrano, C. Dunod, A. Wartel-Tram, N. Jackson, C.P. Simmons, Genetic epidemiology of dengue viruses in phase iii trials of the cyd tetravalent dengue vaccine and implications for efficacy, Elife 5 (2017) 24196.","DOI":"10.7554\/eLife.24196.056"},{"key":"10.1016\/j.humimm.2021.09.006_b0160","doi-asserted-by":"crossref","unstructured":"C.J. Villabona-Arenas, P.M.d.A. Zanotto, Worldwide spread of dengue virus type 1, PLoS One 8 (2013) e62649-e62649. 10.1371\/journal.pone.0062649.","DOI":"10.1371\/journal.pone.0062649"},{"issue":"1","key":"10.1016\/j.humimm.2021.09.006_b0165","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1006\/viro.2002.1447","article-title":"Phylogenetic relationships and differential selection pressures among genotypes of dengue-2 virus","volume":"298","author":"Twiddy","year":"2002","journal-title":"Virology"},{"issue":"4","key":"10.1016\/j.humimm.2021.09.006_b0170","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.meegid.2008.10.005","article-title":"Phylogeography and evolutionary history of dengue virus type 3","volume":"9","author":"Ara\u00fajo","year":"2009","journal-title":"Infect. Genet. Evol."},{"issue":"8","key":"10.1016\/j.humimm.2021.09.006_b0175","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1016\/j.meegid.2012.07.009","article-title":"Influence of evolutionary events on the indian subcontinent on the phylogeography of dengue type 3 and 4 viruses","volume":"12","author":"Patil","year":"2012","journal-title":"Infect. Genet. Evol."},{"key":"10.1016\/j.humimm.2021.09.006_b0180","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1111\/biom.12016","article-title":"Mark-specific hazard ratio model with multivariate continuous marks: An application to vaccine efficacy","volume":"69","author":"Juraska","year":"2013","journal-title":"Biometrics"},{"key":"10.1016\/j.humimm.2021.09.006_b0185","doi-asserted-by":"crossref","unstructured":"G.N. Malavige, T. Rostron, L.T. Rohanachandra, S.D. Jayaratne, N. Fernando, A.D. De Silva, M. Liyanage, G. Ogg, Hla class i and class ii associations in dengue viral infections in a sri lankan population, PLoS One 6 (2011) e20581-e20581. 10.1371\/journal.pone.0020581.","DOI":"10.1371\/journal.pone.0020581"},{"key":"10.1016\/j.humimm.2021.09.006_b0190","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0115619","article-title":"Hla-a*33:01 as protective allele for severe dengue in a population of filipino children","volume":"10","author":"Mercado","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/j.humimm.2021.09.006_b0195","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/nrmicro.2015.2","article-title":"Dengue vaccine: Hypotheses to understand cyd-tdv-induced protection","volume":"14","author":"Guy","year":"2016","journal-title":"Nat. Rev. Micro."},{"key":"10.1016\/j.humimm.2021.09.006_b0200","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2017.01372","article-title":"Complexity of human antibody response to dengue virus: Implication for vaccine development","volume":"8","author":"Tsai","year":"2017","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.humimm.2021.09.006_b0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.humimm.2020.06.010","article-title":"Next-generation sequencing of 11 hla loci in a large dengue vaccine cohort from the philippines","author":"Geretz","year":"2020","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.humimm.2021.09.006_b0210","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0221179","article-title":"Phylogenetic analysis revealed the co-circulation of four dengue virus serotypes in southern thailand","volume":"14","author":"Hamel","year":"2019","journal-title":"PLoS ONE"},{"key":"10.1016\/j.humimm.2021.09.006_b0215","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0207220","article-title":"Emergence of genotype cosmopolitan of dengue virus type 2 and genotype iii of dengue virus type 3 in thailand","volume":"13","author":"Phadungsombat","year":"2018","journal-title":"PLoS ONE"}],"container-title":["Human Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885921002366?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885921002366?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T11:55:48Z","timestamp":1759319748000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0198885921002366"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["S0198885921002366"],"URL":"https:\/\/doi.org\/10.1016\/j.humimm.2021.09.006","relation":{},"ISSN":["0198-8859"],"issn-type":[{"value":"0198-8859","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Associations of human leukocyte antigen with neutralizing antibody titers in a tetravalent dengue vaccine phase 2 efficacy trial in Thailand","name":"articletitle","label":"Article Title"},{"value":"Human Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humimm.2021.09.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Inc. on behalf of American Society for Histocompatibility and Immunogenetics.","name":"copyright","label":"Copyright"}]}}